{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:46:50Z","timestamp":1792050410275,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.oret.2026.09.030","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:52:07Z","timestamp":1792047127000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Complex Retinal Detachment Repair with Proliferative Vitreoretinopathy Grade C using the Cincinnati Methotrexate Protocol"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8344-3605","authenticated-orcid":false,"given":"Denis","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6539-3250","authenticated-orcid":false,"given":"Jack E.","family":"Feist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2608-3265","authenticated-orcid":false,"given":"Sloane A.","family":"McTavish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1098-7131","authenticated-orcid":false,"given":"Muhammad Jehanzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0328-7927","authenticated-orcid":false,"given":"Robert A.","family":"Sisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke B.","family":"Lindsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Osher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1460-0117","authenticated-orcid":false,"given":"Daniel M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4675-6076","authenticated-orcid":false,"given":"Robert K.","family":"Hutchins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon A.","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan R.","family":"Abdulaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8652-4563","authenticated-orcid":false,"given":"Chloe T.L.","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujaja","family":"Tauqeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Riemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.oret.2026.09.030_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/IIO.0000000000000258","article-title":"Proliferative Vitreoretinopathy: A Review","volume":"59","author":"Idrees","year":"2019","journal-title":"Int Ophthalmol Clin"},{"issue":"12","key":"10.1016\/j.oret.2026.09.030_bib2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1097\/IAE.0000000000003250","article-title":"STRUCTURAL AND FUNCTIONAL MACULAR CHANGES AFTER RETINECTOMY FOR RETINAL DETACHMENT COMPLICATED BY PROLIFERATIVE VITREORETINOPATHY","volume":"41","author":"Grassi","year":"2021","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.oret.2026.09.030_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1001\/archopht.1997.01100150337005","article-title":"Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11","volume":"115","author":"Abrams","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.oret.2026.09.030_bib4","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.ophtha.2006.05.039","article-title":"Outcomes of Vitrectomy with Inferior Retinectomy in Patients with Recurrent Rhegmatogenous Retinal Detachments and Proliferative Vitreoretinopathy","volume":"113","author":"Quiram","year":"2006","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.oret.2026.09.030_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9394(03)00241-1","article-title":"Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study","volume":"136","author":"Scott","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.oret.2026.09.030_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archopht.1997.01100150337005","article-title":"Vitrectomy With Silicone Oil or Long-Acting Gas in Eyes With Severe Proliferative Vitreoretinopathy: Results of Additional and Long-term Follow-up: Silicone Study Report 11","volume":"115","author":"Abrams","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.oret.2026.09.030_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-199313040-00002","article-title":"VITRECTOMY WITH SILICONE OIL OR PERFLUOROPROPANE GAS IN EYES WITH SEVERE PROLIFERATIVE VITREORETINOPATHY: Silicone Study Report No. 3","volume":"13","author":"Mccuen","year":"1993","journal-title":"RETINA"},{"issue":"7","key":"10.1016\/j.oret.2026.09.030_bib8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/bjo.2007.131540","article-title":"Predicting visual outcome following retinectomy for retinal detachment","volume":"92","author":"De Silva","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"14","key":"10.1016\/j.oret.2026.09.030_bib9","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1038\/s41433-024-03109-x","article-title":"The Wisconsin silicone oil study (report #1): anatomical and functional outcomes of repair of retinal detachment with proliferative vitreoretinopathy","volume":"38","author":"Schildroth","year":"2024","journal-title":"Eye"},{"issue":"12","key":"10.1016\/j.oret.2026.09.030_bib10","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4103\/IJO.IJO_2840_23","article-title":"Outcomes after giant peripheral retinotomy and anterior flap retinectomy for rhegmatogenous retinal detachments with advanced proliferative vitreoretinopathy using small gauge vitrectomy","volume":"72","author":"Agarwal","year":"2024","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"10.1016\/j.oret.2026.09.030_bib11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/jcp.24606","article-title":"Disease Pathways in Proliferative Vitreoretinopathy: An Ongoing Challenge","volume":"229","author":"Tosi","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.oret.2026.09.030_bib12","doi-asserted-by":"crossref","unstructured":"Claes C, Lafet\u00e1 AP. Proliferative Vitreoretinopathy. In: Oh H, Oshima Y, eds. Developments in Ophthalmology. Vol 54. S. Karger AG; 2014:188-195. doi:10.1159\/000360466","DOI":"10.1159\/000360466"},{"key":"10.1016\/j.oret.2026.09.030_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.preteyeres.2015.07.005","article-title":"Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences","volume":"51","author":"Pastor","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2026.09.030_bib14","unstructured":"Eliott D, Stryjewski T. Methotrexate for Proliferative Vitreoretinopathy. WO 2016\/019165 A1. Published February 4, 2016."},{"key":"10.1016\/j.oret.2026.09.030_bib15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2147\/OPTH.S111893","article-title":"Intravitreal methotrexate infusion for proliferative vitreoretinopathy","volume":"10","author":"Sadaka","year":"2016","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"2","key":"10.1016\/j.oret.2026.09.030_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/24741264221135799","article-title":"Intraocular Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy: A Review","volume":"7","author":"McAllister","year":"2023","journal-title":"J Vitreoretin Dis"},{"issue":"11","key":"10.1016\/j.oret.2026.09.030_bib17","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1097\/IAE.0000000000004602","article-title":"REAL-WORLD EFFICACY OF INTRAVITREAL METHOTREXATE FOR MANAGING PROLIFERATIVE VITREORETINOPATHY IN RECURRENT RHEGMATOGENOUS RETINAL DETACHMENT","volume":"45","author":"Yun","year":"2025","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.oret.2026.09.030_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3928\/23258160-20230220-01","article-title":"Low-Dose Intravitreal Methotrexate for Proliferative Vitreoretinopathy","volume":"54","author":"Ullah","year":"2023","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2026.09.030_bib19","unstructured":"Aldeyra Therapeutics. Aldeyra Therapeutics Achieves Primary Endpoint in Part 1 of Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy. Published online October 6, 2022. Accessed June 14, 2026. https:\/\/ir.aldeyra.com\/news-releases\/news-release-details\/aldeyra-therapeutics-achieves-primary-endpoint-part-1-phase-3"},{"key":"10.1016\/j.oret.2026.09.030_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/24741264251323305","article-title":"Postoperative Methotrexate to Reduce Reoperation Rate and Improve Vision in Patients With Complex Retinal Detachments, Advanced Diabetic Retinopathy, and Trauma","author":"Gibson","year":"2025","journal-title":"J Vitreoretin Dis"},{"issue":"3","key":"10.1016\/j.oret.2026.09.030_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.51329\/mehdiophthal1452","article-title":"Intravitreal methotrexate infusion for prophylaxis of proliferative vitreoretinopathy after pars plana vitrectomy for rhegmatogenous retinal detachment","volume":"11","author":"Fouad","year":"2022","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"10.1016\/j.oret.2026.09.030_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/3648134","article-title":"Anatomical and Functional Outcomes of Vitrectomy with\/without Intravitreal Methotrexate Infusion for Management of Proliferative Vitreoretinopathy Secondary to Rhegmatogenous Retinal Detachment","volume":"2021","author":"El Baha","year":"2021","journal-title":"J Ophthalmol"},{"issue":"10","key":"10.1016\/j.oret.2026.09.030_bib23","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1097\/IAE.0000000000004181","article-title":"INTRAVITREAL METHOTREXATE INJECTION FOR THE TREATMENT AND PREVENTION OF PROLIFERATIVE VITREORETINOPATHY","volume":"44","author":"Hughes","year":"2024","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.oret.2026.09.030_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79708-1","article-title":"Effects of repeated intra-silicone oil injections of methotrexate on proliferative vitreoretinopathy grade C: a multicenter randomized controlled trial","volume":"14","author":"Nourinia","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.oret.2026.09.030_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/09273948.2019.1597894","article-title":"Intra-silicone Oil Injection of Methotrexate in Retinal Reattachment Surgery for Proliferative Vitreoretinopathy","volume":"28","author":"Falavarjani","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.oret.2026.09.030_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2019-000293","article-title":"Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy","volume":"4","author":"Benner","year":"2019","journal-title":"BMJ Open Ophthalmol"},{"issue":"10","key":"10.1016\/j.oret.2026.09.030_bib27","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s00417-021-05206-z","article-title":"Adjunctive serial post-operative intravitreal methotrexate injections in the management of advanced proliferative vitreoretinopathy","volume":"259","author":"Roca","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.oret.2026.09.030_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.oret.2023.01.015","article-title":"Risk of Tertiary, Quaternary, and Quinary Proliferative Vitreoretinopathy","volume":"7","author":"Aziz","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.oret.2026.09.030_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1350-9462(97)00007-4","article-title":"Risk factors for proliferative vitreoretinopathy","volume":"17","author":"Nagasaki","year":"1998","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2026.09.030_bib30","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/OPTH.S27896","article-title":"Sadaka. Proliferative vitreoretinopathy: current and emerging treatments","author":"Giuliari","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.oret.2026.09.030_bib31","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1167\/iovs.10-5768","article-title":"TNF\u03b1 Is Required for Late BRB Breakdown in Diabetic Retinopathy, and Its Inhibition Prevents Leukostasis and Protects Vessels and Neurons from Apoptosis","volume":"52","author":"Huang","year":"2011","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.oret.2026.09.030_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110482","article-title":"Commonalities between fibrotic and inflammatory mechanisms in proliferative vitreoretinopathy and proliferative diabetic retinopathy","volume":"258","author":"Sreenivas Bk","year":"2025","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.oret.2026.09.030_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajo.2007.10.015","article-title":"Retinal Redetachment after Silicone Oil Removal in Proliferative Vitreoretinopathy: A Prognostic Factor Analysis","volume":"145","author":"Lam","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.oret.2026.09.030_bib34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/archopht.1994.01090180076038","article-title":"The Effects of Silicone Oil Removal: Silicone Study Report 6","volume":"112","author":"Hutton","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.oret.2026.09.030_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.18240\/ijo.2022.08.09","article-title":"Outcomes and predictors of vitrectomy and silicone oil tamponade in retinal detachments complicated by proliferative vitreoretinopathy","volume":"15","author":"Sonmez","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"10.1016\/j.oret.2026.09.030_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.oret.2024.10.006","article-title":"A Modified Intravitreal Methotrexate Protocol for the Prevention of Proliferative Vitreoretinopathy after Silicone Oil Removal","volume":"9","author":"Liu","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"10.1016\/j.oret.2026.09.030_bib37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjophthalmol-2021-320121","article-title":"Risk factors for epiretinal membrane in eyes with primary rhegmatogenous retinal detachment that received silicone oil tamponade","volume":"107","author":"Pan","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.oret.2026.09.030_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.oret.2025.06.006","article-title":"Internal Limiting Membrane Peeling for Grade C Proliferative Vitreoretinopathy","volume":"10","author":"Wakabayashi","year":"2026","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"10.1016\/j.oret.2026.09.030_bib39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bjo.79.10.874","article-title":"Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease","volume":"79","author":"Mietz","year":"1995","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.oret.2026.09.030_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51633-8","article-title":"Characterisation of the inflammatory cytokine and growth factor profile in a rabbit model of proliferative vitreoretinopathy","volume":"9","author":"Wong","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2026.09.030_bib41","unstructured":"Riemann CD. Interim Report of the FIXER Trial: Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair. Podium Presentation presented at: Annual ASRS Meeting; August 2, 2025; Long Beach, CA."},{"key":"10.1016\/j.oret.2026.09.030_bib42","unstructured":"EyeCare Partners Doc 2 Doc Podcast: FIXER-Methotrexate Trial. Published online November 2025. Accessed June 6, 2026. https:\/\/www.youtube.com\/watch?v=gYrpZ44Kev4"},{"key":"10.1016\/j.oret.2026.09.030_bib43","unstructured":"Franklin AJ, Gibson Snellings L, Nguyen A, Riemann CD. Methotrexate: An Emerging Surgical Adjuvant. January 2026. Accessed June 6, 2026. https:\/\/retinatoday.com\/articles\/2026-jan-feb\/methotrexate-an-emerging-surgical-adjuvant"},{"key":"10.1016\/j.oret.2026.09.030_bib44","unstructured":"Riemann CD. Methotrexate for PVR Prevention: Interim Report of the Prospective FIXER RCT. Invited Lecture at 10th Annual FLORetina Conference presented at: FLORetina; December 6, 2025; Florence, Italy."}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026005233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026005233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:52:14Z","timestamp":1792047134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653026005233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"alternative-id":["S2468653026005233"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2026.09.030","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Complex Retinal Detachment Repair with Proliferative Vitreoretinopathy Grade C using the Cincinnati Methotrexate Protocol","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2026.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}